Skip to main content

Volume 26 - Issue 11 - November 2018

Column

Voices
12/04/2018
PPACMAN is a non-profit organization with a mission to enhance comanagement of patients with psoriasis and PsA among rheumatologists and dermatologists and to improve early identification of PsA.
PPACMAN is a non-profit organization with a mission to enhance comanagement of patients with psoriasis and PsA among rheumatologists and dermatologists and to improve early identification of PsA.
PPACMAN is a non-profit...
12/04/2018
The Dermatologist

Feature

NEA Approved Features
12/04/2018
JAK inhibitors appear to be effective for the treatment of AD, and this class of medications will influence the current paradigm of AD management.
JAK inhibitors appear to be effective for the treatment of AD, and this class of medications will influence the current paradigm of AD management.
JAK inhibitors appear to be...
12/04/2018
The Dermatologist